An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Pharming Group N.V. announces it will release its first quarter 2024 financial results on May 8, 2024. The company will present the preliminary unaudited report for the period ending March 31. Analysts and investors can join a conference call on the same day at 13:30 CEST/07:30 am EDT. To participate, registration is required. A live webcast will also be available for viewing.
Pharming Group N.V. annuncia che pubblicherà i risultati finanziari del primo trimestre 2024 l'8 maggio 2024. La società presenterà il rapporto preliminare non revisionato per il periodo conclusosi il 31 marzo. Gli analisti e gli investitori possono partecipare a una conferenza telefonica nello stesso giorno alle 13:30 CEST/07:30 EDT. È necessaria la registrazione per partecipare. Sarà inoltre disponibile una trasmissione web in diretta.
Pharming Group N.V. anuncia que publicará los resultados financieros del primer trimestre de 2024 el 8 de mayo de 2024. La empresa presentará el informe preliminar no auditado correspondiente al periodo que finaliza el 31 de marzo. Analistas e inversores pueden unirse a una llamada de conferencia ese mismo día a las 13:30 CEST/07:30 am EDT. Se requiere inscripción para participar. También estará disponible una transmisión en vivo por internet.
Pharming Group N.V.는 2024년 첫 분기 재무 결과를 2024년 5월 8일에 발표할 것이라고 밝혔습니다. 회사는 3월 31일에 종료된 기간에 대한 예비 미감사 보고서를 제출할 것입니다. 분석가 및 투자자는 같은 날 13:30 CEST/07:30am EDT에 열리는 컨퍼런스 콜에 참여할 수 있습니다. 참가하려면 등록이 필요합니다. 라이브 웹캐스트도 시청 가능할 예정입니다.
Pharming Group N.V. annonce qu'elle publiera ses résultats financiers du premier trimestre 2024 le 8 mai 2024. L'entreprise présentera le rapport préliminaire non audité pour la période se terminant le 31 mars. Les analystes et les investisseurs peuvent participer à une téléconférence le même jour à 13h30 CEST/07h30 EDT. L'inscription est nécessaire pour participer. Une webdiffusion en direct sera également disponible.
Pharming Group N.V. gibt bekannt, dass sie ihre Finanzergebnisse für das erste Quartal 2024 am 8. Mai 2024 veröffentlichen wird. Das Unternehmen wird den vorläufigen ungeprüften Bericht für den Zeitraum bis zum 31. März präsentieren. Analysten und Investoren können am gleichen Tag um 13:30 CEST/07:30 am EDT an einer Telefonkonferenz teilnehmen. Eine Anmeldung ist erforderlich. Eine Live-Webübertragung wird ebenfalls verfügbar sein.
Positive
None.
Negative
None.
Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) first quarter 2024 financial results, for the period ended March 31, on Wednesday, May 8, 2024.
Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 am EDT on May 8, 2024.
To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.
Conference call registration:
Please note, the Company will only take questions from dial-in attendees.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
Pharming Group, Leiden, The Netherlands Michael Levitan, VP Investor Relations & Corporate Communications T: +1 (908) 705 1696 E: investor@pharming.com
FTI Consulting, London, UK Victoria Foster Mitchell/Alex Shaw/Amy Byrne T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, The Netherlands Leon Melens T: +31 6 53 81 64 27 E: pharming@lifespring.nl
FAQ
When will Pharming Group report its first quarter 2024 financial results?
Pharming Group will report its first quarter 2024 financial results on May 8, 2024.
What is the date of the period covered in Pharming Group's first quarter 2024 financial results?
The period covered in Pharming Group's first quarter 2024 financial results is from January 1 to March 31, 2024.
How can analysts and investors participate in Pharming Group's conference call for the first quarter 2024 financial results?
Analysts and investors can participate in Pharming Group's conference call for the first quarter 2024 financial results by registering in advance using the provided link.
What time will Pharming Group host the presentation for analysts and investors on May 8, 2024?
Pharming Group will host the presentation for analysts and investors at 13:30 CEST/07:30 am EDT on May 8, 2024.
Where can one watch the live webcast of Pharming Group's first quarter 2024 financial results presentation?
To watch the live webcast of Pharming Group's first quarter 2024 financial results presentation, one can register in advance using the provided webcast registration link.
